[P66] Poster Session 66　Breast Cancer（Metastatic）

[P66-8] SERENA-4: Phase III trial of AZD9833 + palbociclib versus anastrozole + palbo-ciclib, in ER+/HER2- advanced breast cancer

^○Hiroji Iwata¹, Andre Fabrice², Im Seock-Ah³, Neven Patrick⁴, D Baird Richard⁵, Ettl Johannes⁶, P Goetz Matthew⁷, Hamilton Erika⁸, Jiang Zefei⁹, Abraham Joy Anil¹⁰, Haddad Vincent¹¹, Walding Andrew¹², Selvi Miralles Manuel¹², Huang-Bartlett Cynthia¹², Llombart-Cussac Antonio¹³ (1.Aichi Cancer Center Hospital, 2.Institut Gustave Roussy, 3.Seoul National University Hospital, 4.Universitair Ziekenhuis, 5.Cancer Research UK Cambridge Centre, 6.Technical University of Munich, 7.Mayo Clinic, 8.Sarah Cannon Research Institute and Tennessee Oncology, 9.The Fifth Medical Centre of Chinese PLA General Hospital, 10.Department of Oncology, University of Alberta, Cross Cancer Institute, 11.Oncology Biometrics, AstraZeneca, 12.Late Development, Oncology R&D, AstraZeneca, 13.Hospital Arnau de Vilanova)